| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $858K | — | +16.7% |
| Cost of Revenue | $353K | — | +20.5% |
| Gross Profit | $505K | — | +14.3% |
| R&D Expense | $404K | — | +676.9% |
| SG&A Expense | $9.9M | — | -14.9% |
| Operating Income | $96.8M | — | +458.3% |
| Interest Expense | $1.4M | — | -12.9% |
| Income Tax | $12.2M | — | — |
| Net Income | $41.7M | — | +236.8% |
| EPS (Basic) | -$0.27 | — | -212.5% |
| EPS (Diluted) | -$0.26 | — | -208.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $289.8M | +67.3% | +195.2% |
| Accounts Receivable | $157K | +1021.4% | +41.4% |
| Current Assets | $301.5M | +67.3% | +163.9% |
| Total Assets | $594.3M | +23.0% | +43.4% |
| Current Liabilities | $48.2M | -10.5% | +29.7% |
| Total Liabilities | $48.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.3M | — | -168.2% |
| Capital Expenditures | $597K | — | — |
| Investing Cash Flow | $115.2M | — | — |
| Financing Cash Flow | $43.0M | — | -39.3% |
| Free Cash Flow | -$42.9M | — | -172.0% |
| -50.9% |
| Stockholders' Equity | $540.3M | +29.8% | +76.0% |